Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Eribulin Eisai 0.44 mg/ml solution for injection

Active Ingredient:
eribulin mesylate
Company:  
Eisai Ltd See contact details
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 11 Dec 2024
{pdf} View or print the patient leaflet as PDF
Eisai Ltd
Company image
Address
EMEA Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN
Telephone
+44(0)208 600 1400
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)208 600 1400
WWW
http://www.eisai.eu